Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Johnson & Johnson Touts Growth From New Drugs Zytiga, Edurant
Johnson & Johnson Touts Growth From New Drugs Zytiga, Edurant
Johnson & Johnson Touts Growth From New Drugs Zytiga, Edurant
Submitted by
admin
on May 27, 2011 - 8:53am
Source:
Minyanville
News Tags:
JNJ
Edurant
Zytiga
prostate cancer
HIV
AIDS
Headline:
Johnson & Johnson Touts Growth From New Drugs Zytiga, Edurant
Do Not Allow Advertisers to Use My Personal information
